Should a patient with a single episode of microscopic hematuria (presence of red blood cells in urine) undergo a full evaluation or have a repeat urinalysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A single bout of microscopic hematuria should be fully evaluated rather than simply repeating the urinalysis, as recommended by the American Urological Association (AUA) and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) guideline published in 2020 1. The evaluation should include a detailed medical history, physical examination, and additional testing such as urine culture, imaging studies, and possibly cystoscopy. This comprehensive approach is recommended because microscopic hematuria can be a sign of serious underlying conditions including urinary tract malignancies, kidney disease, or urinary stones, even when it occurs just once.

  • Key factors to consider in the evaluation include:
    • Age, with adults over 35 years old being at higher risk for underlying malignancy
    • Smoking history and occupational exposures, which increase the risk of urothelial cancer
    • Degree and persistence of microhematuria, with 3 or more red blood cells per high-power field on microscopic examination of urinary sediment defining microhematuria
    • Prior gross hematuria, which may indicate a higher risk for genitourinary malignancy According to the AUA/SUFU guideline, a risk classification system should be used to stratify patients as low-, intermediate-, or high-risk for genitourinary malignancy, and diagnostic evaluation with cystoscopy and upper tract imaging should be recommended according to patient risk and involving shared decision-making 1.
  • The guideline also recommends repeating urinalysis following resolution of a gynecologic or non-malignant genitourinary cause of microhematuria, but this does not preclude the need for a thorough initial evaluation to rule out more serious conditions. In clinical practice, delaying evaluation risks missing significant pathology, and prompt evaluation is particularly important in higher-risk populations.

From the Research

Evaluation of Microscopic Hematuria

  • Microscopic hematuria is a common finding on routine urinalysis of adults, and its evaluation is crucial to determine the underlying cause 2, 3.
  • The exact definition of microscopic hematuria is debated, but it is generally defined as > 3 red blood cells/high power microscopic field 2.
  • The causes of hematuria are extensive, and the most common differential diagnosis for both microscopic and gross hematuria in adults includes infection, malignancy, and urolithiasis 2.

Approach to Evaluation

  • In patients with suspected microscopic hematuria, urine dipstick testing may suggest the presence of blood, but results should be confirmed with a microscopic examination 4.
  • The evaluation of microscopic hematuria should include renal function testing, urinary tract imaging, and cystoscopy in the absence of obvious causes 4.
  • Patients with proteinuria, red cell casts, and elevated serum creatinine levels should be referred promptly to a nephrology subspecialist 3.
  • Microscopic hematuria with signs of urinary tract infection should resolve with appropriate treatment of the underlying infection 3.

Repeat Analysis and Referral

  • Persistent microscopic hematuria indicates the presence of a renal disease that warrants close monitoring and evaluation 5.
  • Prompt referral to a pediatric nephrologist is indicated in situations when hematuria does not resolve within 2 weeks of onset of glomerulonephritis, there is a need for a renal biopsy, in the presence of persistent microscopic hematuria, and need for specific urine biochemistry testing or imaging studies 5.
  • Patients who have no identifiable cause after an extensive workup should be monitored for early detection of malignancy or occult renal disease 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hematuria: etiology and evaluation for the primary care physician.

The Canadian journal of urology, 2008

Research

Assessment of microscopic hematuria in adults.

American family physician, 2006

Research

Approach to Diagnosis and Management of Hematuria.

Indian journal of pediatrics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.